Proteomic characterization of the angiogenesis inhibitor SU6668 reveals multiple impacts on cellular kinase signaling.
Godl K, Gruss OJ, Eickhoff J, Wissing J, Blencke S, Weber M, Degen H, Brehmer D, Orfi L, Horváth Z, Kéri G, Müller S, Cotten M, Ullrich A, Daub H.
Godl K, et al. Among authors: keri g.
Cancer Res. 2005 Aug 1;65(15):6919-26. doi: 10.1158/0008-5472.CAN-05-0574.
Cancer Res. 2005.
PMID: 16061676
Free article.